HOUSE_OVERSIGHT_024821.jpg
This Cowen report page discusses the global regulatory landscape for CBD, highlighting developments in Europe and Latin America, and analyzes the U.S. regulatory outlook following the 2018 Farm Bill. It details the shifting oversight from the DEA to the Department of Agriculture while noting continued FDA authority and regulatory uncertainty regarding CBD products.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein relationship